Anita Afzali

Anita Afzali, MD

  • Gastroenterology
  • Physician

Insurances We Accept

About Me

As a gastroenterologist at The Ohio State University Wexner Medical Center and medical director of The Ohio State University Inflammatory Bowel Disease Center, I specialize in caring for and treating patients with inflammatory bowel disease (IBD). I enjoy providing compassionate and comprehensive care to my patients.

My areas of research include the clinical outcomes and risks of IBD therapy, pharmacopidemiology, pharmacoeconomics and pregnant women with inflammatory bowel disease.

In collaboration with Seattle Children’s Hospital, I developed the first pediatric to adult IBD transition clinic in the Northwest. I’ve written several peer-reviewed publications and have been invited to lecture on many national and international programs.

I enjoy working at an academic medical center, where we’re able to provide excellent patient care, participate in research and train the next generation of physicians.
  • Abercrombie and Fitch Endowed Chair in Inflammatory Bowel Disease
  • Co-chair, Crohn’s and Colitis National Professional Education Committee (NPEC)
  • Minority Affairs and Cultural Diversity Committee Member of the American College of Gastroenterology
  • Board Member/Founder: IBD Horizons® (nonprofit IBD accredited organization)

Procedures and Conditions I Treat

  • Crohn Disease
  • Colitis, Ulcerative
  • Inflammatory Bowel Diseases

My Videos

Education and Training

Education History

Medical School

University of Washington School of Medicine, Seattle, WA
8/1/2002 - 6/30/2006


University of Washington Medical Center, Seattle, WA

6/1/2006 - 6/30/2008


University of Washington Medical Center, Seattle, WA

7/1/2008 - 6/30/2012


University of Washington Medical Center, Seattle, WA

7/1/2011 - 6/30/2012

Board Certification

American Board of Internal Medicine (Subspecialty: Gastroenterology)

Academic Information

My Department

Internal Medicine

My Division

Gastroenterology, Hepatology and Nutrition

Consulting and Related Relationships

At The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the University requires annual disclosures from all faculty members with external interests related to their University responsibilities.

As of 11/01/2020, Dr. Afzali has reported relationships with the companies or entities listed below. If you have questions about the relationships listed below, please ask the faculty member. If you have questions about how these relationships are monitored by The Ohio State University Wexner Medical Center, please contact our Compliance Office.

  • Celgene Corporation
  • Gilead Sciences, Inc.
  • Pfizer, Inc.
  • Takeda Pharmaceutical Company
  • IBD Horizons
  • AbbVie Inc.
  • Janssen Biotech
  • Diasorin Inc.
  • MedEdConsulting